Company profile
GenomeKey
GenomeKey enables targeted Sepsis treatment in hours, rather than days
- Industry
- Biotechnology
- Employees
- 35
- Headquarters
- Bristol
- Founded
- 2019
- Office locations
- 1
GenomeKey company summary
GenomeKey is a company in the Biotechnology industry, headquartered in Bristol, founded in 2019. On LinkedIn the company has around 35 employees. Its listed specialties include Machine Learning, A.I., Bioinformatics, Microbiology.
What technology does GenomeKey use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About GenomeKey
GenomeKey enables targeted Sepsis treatment in hours, rather than days. This is important because Sepsis now kills more people than cancer. It can hit anyone, of any age, and kills within hours. A patient admitted to a hospital today, they wait 3 days before the doctor knows which antibiotic will fight the infection. We use cutting edge machine learning and DNA sequencing to bring 3 days down to just a few hours, with the only affordable test that provides a result for every patient. This saves lives, saves money, and saves our last antibiotics for when we really need them.
Specialties
Where is GenomeKey located?
GenomeKey lists 1 location.
Compare companies similar to GenomeKey
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
GenomeKey genomekey.com | Biotechnology | 35 | 2019 | Bristol |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about GenomeKey
What does GenomeKey do?
GenomeKey enables targeted Sepsis treatment in hours, rather than days. This is important because Sepsis now kills more people than cancer. It can hit anyone, of any age, and kills within hours. A patient admitted to a hospital today, they wait 3 days before the doctor knows which antibiotic will fight the infection. We use cutting edge machine learning and DNA sequencing to bring 3 days down to just a few hours, with the only affordable test that provides a result for every patient. This saves lives, saves money, and saves our last antibiotics for when we really need them.
How many employees does GenomeKey have?
GenomeKey has around 35 employees on LinkedIn.
Where is GenomeKey headquartered?
GenomeKey is headquartered in Bristol.
When was GenomeKey founded?
GenomeKey was founded in 2019.
Build a lead list from companies like GenomeKey
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.